AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
Latest news
Events
ISREC Foundation Minisymposium | June 16th
Events

AGORA PRS Seminar | June 17th
Events
Ludwig Distinguished Lecture, Prof. Chris Goodnow | June 19th
Events
Oncology Grand Rounds, Post ASCO – Part Two | June 20th
Events

AGORA Tumor Microenvironment Journal Club
Events

ISREC-SCCL Symposium 2025 | September 1–4
Latest publications
Phage display enables machine learning discovery of cancer antigen-specific TCRs.
Croce G, Lani R, Tardivon D, (…), Hebeisen M, Dunn SM, Gfeller D
Science advances – 2025 Jun 11
Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor control.
Chriqui LE, Marie DN, Sifis A, (…), Joyce J, Cavin S, Perentes JY
Journal for immunotherapy of cancer – 2025 Jun 10
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.
Mazziotta F, Martin LE, Egan DN, (…), Milano F, Greenberg PD, Chapuis AG
Nature communications – 2025 Jun 5
Delineation of the Human Germinal Centre Immune Landscape Using Multiplex Imaging Analysis.
Georgakis S, Orfanakis M, Fenwick C, (…), Gottardo R, Pantaleo G, Petrovas C
Immunology – 2025 May 27
IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against pancreatic cancer in mice with obesity.
Talele NP, Kumra H, Gomes-Santos IL, (…), Pittet MJ, Fukumura D, Jain RK
Journal for immunotherapy of cancer – 2025 May 24